Ophthalmic compositions comprising emedastine and methods for their use
AssigneeAlcon Laboratories, Inc.
InventorsJohn M. Yanni, Stella M. Robertson, Shigetoshi Okumura, Hitoshi Tanaka, Tadayuki Saito
Life of this patent
Estimating the term…
Abstract
Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating ocular allergies, especially allergic conjunctivitis, giant papillary conjunctivitis, and vernal conjunctivitis.
Claims5
A method for treating the pruritus and/or edema associated with giant papillary conjunctivitis and vernal conjunctivitis, comprising topically administering to an affected eye an antihistaminic effective amount of a compound selected from the group consisting of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts.
Dependencies are inferred from the claim text.